MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol

por Arantes, Lidia Maria Rebolho Batista, Laus, Ana Carolina, Melendez, Matias Eliseo, de Carvalho, Ana Carolina, Sorroche, Bruna Pereira, De Marchi, Pedro Rafael Martins, Evangelista, Adriane Feijó, Scapulatempo-Neto, Cristovam, de Souza Viana, Luciano, Carvalho, André Lopes
Publicado 2016

Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial

por D’Almeida Preto, Daniel, Baston, Mariana Toledo, Geraige, Camilla Centurion, Augusto, Sarah Bertazzi, de Oliveira, Marco Antonio, Mamere, Augusto Elias, Pinto, Gustavo Dix Junqueira, Dias, Josiane Mourão, De Marchi, Pedro Rafael Martins, Paiva, Bianca Sakamoto Ribeiro, Paiva, Carlos Eduardo
Publicado 2019